Top compounds associated with response to RYR1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA paclitaxel CCLE pan-cancer AAC 0.099 0.04
mRNA MST-312 CTRPv2 pan-cancer AAC -0.075 0.04
mRNA Topotecan CTRPv2 pan-cancer AAC -0.068 0.04
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.081 0.04
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.1 0.04
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.04
mRNA Axitinib CTRPv2 pan-cancer AAC -0.072 0.04
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.11 0.04
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.062 0.04
Download CSV